Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021843 (
bowel obstruction
)
9,927
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The first published paper on actual IUD insertions was made by Dr. Richard Richter in 1909 in Germany. The device he inserted was a ring made of silkworm gut, with 2 ends which protruded from the cervical os enabling him both to check the device and remove it. In the mid 1920s, Ernest Graefenberg the silkworm gut with a coiled metal ring made of an alloy of copper, nickel, and
zinc
. Although the Graefenberg ring was widely used, it was considered a risky method in continental Europe and in the U.S. As late as 1959, Dr. Alan Guttmacher co-authored a paper in which the IUD was condemned for its ineffectiveness, potential source of infection, and its carcinogenic potential. Since 1960, various kinds of IUDs have been developed, and various organization such as the Population Council showed a renewed interest in IUDs as a contraceptive method. In 1 study of IUD side effects data from 6,450 individuals, there were 10 deaths and 15 instances of
intestinal obstruction
due to the preforation of the intestine by the device; ectopic pregnancies occurred at 10 times the normal rate; however, the vast majority of 56,000 insertions showed the device was well tolerated. Copper devices, such as the Copper-T, promise an even brighter future for the IUD. It is not yet known how the IUD works, but a promising hypothesis is that it promotes the local formation of prostaglandins.
...
PMID:History of intrauterine devices. 109 89
In preparing this Position Statement, all relevant scientific literature was identified and reviewed critically by acknowledged experts using agreed criteria. Well-conducted clinical and experimental studies were given precedence over anecdotal case reports and abstracts were not usually considered. A draft Position Statement was then produced and subjected to detailed peer review by an international group of clinical toxicologists chosen by the American Academy of Clinical Toxicology and the European Association of Poisons Centres and Clinical Toxicologists. The Position Statement went through multiple drafts before being approved by the boards of the two societies and being endorsed by other societies. The Position Statement includes a summary statement for ease of use and is supported by detailed documentation which describes the scientific evidence on which the Statement is based. Whole bowel irrigation (WBI) should not be used routinely in the management of the poisoned patient. Although some volunteer studies have shown substantial decreases in the bioavailability of ingested drugs, no controlled clinical trials have been performed and there is no conclusive evidence that WBI improves the outcome of the poisoned patient. Based on volunteer studies, WBI may be considered for potentially toxic ingestions of sustained-release or enteric-coated drugs. There are insufficient data to support or exclude the use of WBI for potentially toxic ingestions of iron, lead,
zinc
, or packets of illicit drugs; WBI remains a theoretical option for these ingestions. WBI is contraindicated in patients with
bowel obstruction
, perforation, ileus, and in patients with hemodynamic instability or compromised unprotected airways. WBI should be used cautiously in debilitated patients, or in patients with medical conditions that may be further compromised by its use. A single dose of activated charcoal administered prior to WBI does not appear to decrease the binding capacity of charcoal or to alter the osmotic properties of WBI solution. Administration of charcoal during WBI appears to decrease the binding capacity of charcoal.
...
PMID:Position statement: whole bowel irrigation. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. 1119 53
We report a case of small
bowel obstruction
secondary to coin ingestion. A 22-year-old woman presented to the Emergency Department (ED) with a 3-week history of abdominal pain. Upon initial history the patient denied any foreign body ingestion. Only after computed tomography (CT) scanning of the abdomen and pelvis did the patient admit to deliberate ingestion of a single United States penny coin. During surgical evaluation it was found that the coin had lodged near the ileocecal valve and an inflammatory mass had formed around the intraluminal coin, causing a 10 x 7 cm fibrous tumor to completely obstruct the small bowel. It is thought that oxidation of the coin, with subsequent exposure of its high
zinc
content, instigated the inflammatory cascade.
...
PMID:A penny for your thoughts: small bowel obstruction secondary to coin ingestion. 1538 10
The purpose of this study is to evaluate the acute toxicity of oral exposure to nanoscale
zinc
powder in mice. The healthy adult male and female mice were gastro-intestinally administered at a dose of 5 g/kg body weight with two size particles, nanoscale
zinc
(N-Zn) and microscale
zinc
(M-Zn) powder, while one group mice treated with sodium carboxy methyl cellulose was used as the control. The symptoms and mortality after
zinc
powder treatment were recorded. The effects of particles on the blood-element, the serum biochemical level and the blood coagulation were studied after 2 weeks of administration. The organs were collected for histopathological examination. The N-Zn treated mice showed more severe symptoms of lethargy, vomiting and diarrhea in the beginning days than the M-Zn mice. Deaths of two mice occurred in the N-Zn group after the first week of treatment. The mortalities were confirmed by
intestinal obstruction
of the nanoscale
zinc
aggregation. The biochemical liver function tests of serum showed significantly elevated ALT, AST, ALP, and LDH in the M-Zn mice and ALT, ALP, and LDH in the N-Zn mice compared with the controls (P<0.05), which indicated that the liver damage was probably induced by both micro- and nano-scale
zinc
powders. The clinical changes were observed in the two treated group mice as well. The levels of the above enzymes were generally higher in the M-Zn mice than in the N-Zn mice, which implied that M-Zn powder could induce more severe liver damage than N-Zn. The biochemical renal function tests of serum BUN and CR in the M-Zn mice markedly increased either compared with the N-Zn mice or with the controls (P<0.05), but no significant difference was found between the N-Zn and the control mice. However, severe renal lesions were found by the renal histopathological examination in the N-Zn exposed mice. Therefore, we concluded that severe renal damage could occur in the N-Zn treated mice, though no significant change of blood biochemical levels occurred. Blood-element test showed that in the N-Zn mice, PLT and RDW-CV significantly increased, and HGB and HCT significantly decreased compared to the controls, which indicated that N-Zn powder could cause severe anemia. Besides the pathological lesions in the liver, renal, and heart tissue, only slight stomach and intestinal inflammation was found in all the
zinc
treated mice, without significant pathological changes in other organs.
...
PMID:Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. 1616 31